.png)
RAPS Convergence 2025 Booth #421
Date & Time:
October 7, 2025
–
October 9, 2025
EDT
PDT
Location:
Pittsburgh, PA
Speaker:
Event Information
Join Weave at RAPS Convergence 2025 – Brandon Rice Shares Lessons from AI in Regulatory Workflows
We’re excited to announce that Brandon Rice, Chief Product Officer at Weave, will be speaking at RAPS Convergence 2025, the regulatory affairs community’s leading annual event for global healthcare product professionals. Join us in Phoenix to explore forward-thinking solutions shaping the future of regulatory practice.
Talk Details
Title: Lessons from a Comparative Analysis of Old and New Regulatory Processes
Speaker: Brandon Rice, Chief Product Officer, Weave
Date: Wednesday, October 8, 2025
Time: 11:20 AM
Session Overview
What happens when regulatory drafting is optimized with AI? In this session, Brandon will present findings from a real-world collaboration with a Top 20 pharmaceutical company that compared traditional regulatory content development with AI-augmented drafting using a comprehensive toolset.
The results showed significant time savings and measurable gains in quality across drafting, content refinement, and data verification. The session will also offer a practical framework for modernizing regulatory lifecycle management while emphasizing the continued value of human expertise.
Learning Objectives:
- Identify immediate areas to incorporate AI assistance in regulatory workflows
- Leverage quality measures to evaluate AI tools in the market today
- Use the shared framework to set expectations for any future technology adoption
Attendees will gain a grounded, strategic perspective on how AI tools can improve—not replace—scientific and regulatory judgment.
Visit the Weave Booth
Stop by Booth 421 to meet the Weave team and see a live demo of The Weave Platform in action. Learn how Weave’s AI-native solution is helping regulatory teams across the industry accelerate content development, streamline workflows, and maintain control throughout the submission lifecycle.
Whether you're evaluating tools or actively building a future-ready regulatory platform, we’d love to connect.